Back to Awarded Treatment Trials


Awarded Trial: 02T-160

Grant ID

02T-160

Illness

Bipolar Disorder

Primary Drug/Intervention

Methylphenidate

Primary Dosage

20mg/d - 60mg/d

Secondary Drug Intervention

Atomoxetine

Secondary Dosage

Twice-daily dosing of 1.2 mg/kg/day

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Terminated

Investigator

Schweitzer

Sample Size

30

Duration of Study Period for Each Subject

19 weeks

Outcome Measurements

KIDDIE-SADS, YMRS, CGIS, Children's Global Assessment Scale, Conner?s Parent & Teacher Rating Scale, Childhood Depression Rating Scale-Revised

Results

Poor enrollment resulted in termination of this grant.

Publication

N/A

Link

N/A

PI Name

Julie Schweitzer

Degree

PhD

Center

University of Maryland School of Medicine

Institution

MPRC, White Building

Address

P.O. Box 21247

City or Town

Catonsville

State or Province

MD

Zip or Postal Code

21247

Country

USA

Email Address

jschweit@mprc.umaryland.edu